NCT01563354
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Novartis Investigative Site Aarhus, Denmark
- Novartis Investigative Site Copenhagen N, Denmark
- Novartis Investigative Site Toulouse, Cedex 9, France
- Novartis Investigative Site Créteil, France